EPO Patents = 1

Trademarks = 2

Forward Citations = 54

Loading Chart...

4 inventors (with patents filed for the assignee):

Adam S Grossman (7 out of 12 patents)

James J Mond (7 out of 38 patents)

Jerrold B Grossman (5 out of 8 patents)

4. Dov A Goldstein (4 out of 7 patents)

7 patents: Sort by Forward Citations

1. 11084870 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2021-08-10),

2. 10683343 - Compositions and methods for the treatment of immunodeficiency (2020-06-16),

3. 10259865 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2019-04-16),

4. 9969793 - Compositions and methods for the treatment of immunodeficiency (2018-05-15),

5. 9815886 - Compositions and methods for the treatment of immunodeficiency (2017-11-14),

6. 9714283 - Compositions and methods for the treatment of immunodeficiency (2017-07-25),

7. 9107906 - Compositions and methods for the treatment of immunodeficiency (2015-08-18),

Company Overview

Adma Biologics is a commercial-stage biopharmaceutical company that focuses on developing and commercializing treatment for immune deficiencies and infectious diseases. The company's lead product, BIVIGAM, is a intravenous immune globulin used to treat primary humoral immunodeficiency (PI). Adma Biologics is dedicated to improving patient outcomes through innovative biologics therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#7 in Ramsey, NJ

#1,482 in New Jersey

#39,907 in US

Ramsey, NJ, United States of America

Adma Biologics, Inc.

Forward Citations = 54

4 inventors:

Adam S Grossman (7 out of 12 patents)

James J Mond (7 out of 38 patents)

Jerrold B Grossman (5 out of 8 patents)

4. Dov A Goldstein (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adma Biologics, Inc.. Retrieved from https://idiyas.com/company/adma-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]